EUSA Pharma, a newly-established specialty pharmaceutical business, and AVEO Oncology (NASDAQ:A VEO) today announced the submission of a Marketing Authorization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE